Abstract |
In this study, curdlan sulphate - chitosan nanoparticles were prepared through polyelectrolyte complexing at a mass ratio of 2:1 respectively. The curdlan was produced by fermentation with Agrobacterium sp. ATCC 31750, which was then sulphated to form the polyanionic polymer. A first-line tuberculosis drug, Rifampicin and a phytochemical, DdPinitol, were encapsulated into Curdlan Sulphate (CS) - Chitosan Nanoparticles (C) (CSC NPs) of size 205.41 ± 7.24 nm. The drug release kinetics followed a Weibull model with initial burst release (48 % Rifampicin and 27 % d- Pinitol within 6 h), followed by a sustained release. The prepared CSC: d-PIN + RIF NPs was cytocompatible and entered the M.smegmatis infected macrophages through multiple endocytic pathways including clathrin, caveolae and macropinocytosis. They showed superior bactericidal activity (2.4-2.7 fold) within 4 h when compared to free drug Rifampicin (1.6 fold). The drug encapsulated CSC: RIF suppressed the pro-inflammatory gene (TNF-α by 3.66 ± 0.19 fold) and CSC: d-PIN + RIF increased expression of the anti-inflammatory gene (IL-10 by 13.09 ± 0.47 fold). Expression of TGF- β1 gene also increased when treated with CSC: d-PIN + RIF (13.00 ± 0.19 fold) which provided the immunomodulatory activity of the encapsulated CSC NPs. Thus, curdlan sulphate - chitosan polyelectrolyte complex can be a potential nanocarrier matrix for intracellular delivery of multiple drugs.
|
Authors | Radhika Ravindran, Kartik Mitra, Senthil Kumar Arumugam, Mukesh Doble |
Journal | Carbohydrate polymers
(Carbohydr Polym)
Vol. 258
Pg. 117686
(Apr 15 2021)
ISSN: 1879-1344 [Electronic] England |
PMID | 33593559
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021. Published by Elsevier Ltd. |
Chemical References |
- Drug Carriers
- Polyelectrolytes
- Polymers
- beta-Glucans
- chitosan sulfate
- polyanions
- curdlan
- Chitosan
- curdlan sulfate
- Rifampin
|
Topics |
- Animals
- Cell Survival
- Chitosan
(chemistry)
- Drug Carriers
(chemistry)
- Drug Delivery Systems
- Drug Liberation
- Endocytosis
- Hydrogen-Ion Concentration
- Inflammation
- Kinetics
- Macrophages
(drug effects, metabolism, microbiology)
- Mice
- Mycobacterium Infections, Nontuberculous
(drug therapy)
- Mycobacterium smegmatis
(drug effects)
- Nanoparticles
(chemistry)
- Polyelectrolytes
(chemistry)
- Polymers
(chemistry)
- RAW 264.7 Cells
- Rifampin
(pharmacology)
- beta-Glucans
(chemistry)
|